Brook StarRay Wireless Controller Now Available — Native PS5 Support Meets Xbox-Style Control 
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight 
Scalare Launches EquityRoom, Adding a Subscription Revenue Stream to Its Founder Ecosystem 
Megaannum Capital and Zhongke Xianxing Venture Capital Enter into Strategic Partnership Don’t Let Your IoT Devices Threaten Network Security
By Roger Sands, CEO and Co-Founder of Wyebot Internet of Things (IoT) technology is rapidly…
How Cybersecurity Can Keep Pace with Digital Science and AI Capabilities
By Rachel Jenkins Digital science aims to improve old processes with new and innovative technologies,…
PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections
Recruitment to Resume Imminently Top-line Results Expected in Mid-2024 PETACH TIKVA, Israel, May 22, 2023 (GLOBE…
PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections
Recruitment to Resume Imminently Top-line Results Expected in Mid-2024 PETACH TIKVA, Israel, May 22, 2023 (GLOBE…
Medigene AG Expands Patent Portfolio for its End-to-End Platform
Planegg/Martinsried, May 22, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company…
Medigene AG Expands Patent Portfolio for its End-to-End Platform
Planegg/Martinsried, May 22, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company…
Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference
LEXINGTON, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference
LEXINGTON, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
Tilray Brands Chairman and CEO Irwin D. Simon to Participate in the Bernstein 39th Annual Strategic Decisions Conference
NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX:…
Tilray Brands Chairman and CEO Irwin D. Simon to Participate in the Bernstein 39th Annual Strategic Decisions Conference
NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX:…
Quanta Therapeutics Raises Over $50 Million in Series D Financing to Advance its Pipeline of KRAS Inhibitors
– Funds will support advancement of two KRAS inhibitor programs into the clinic in 2024…
Quanta Therapeutics Raises Over $50 Million in Series D Financing to Advance its Pipeline of KRAS Inhibitors
– Funds will support advancement of two KRAS inhibitor programs into the clinic in 2024…
Lumos Pharma to Participate in World Orphan Drug Congress USA
AUSTIN, Texas, May 22, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company…
Lumos Pharma to Participate in World Orphan Drug Congress USA
AUSTIN, Texas, May 22, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company…
Scilex Holding Company Added to the Preliminary List of the Russell 3000® Index and the Small-Cap Russell 2000® Index as part of the 2023 Russell Indexes Annual Reconstitution in June 2023
PALO ALTO, Calif., May 22, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
Scilex Holding Company Added to the Preliminary List of the Russell 3000® Index and the Small-Cap Russell 2000® Index as part of the 2023 Russell Indexes Annual Reconstitution in June 2023
PALO ALTO, Calif., May 22, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients
XBiotech Believes its Drug Candidate Natrunix Could Revolutionize Arthritis Treatment AUSTIN, Texas, May 22, 2023…
FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients
XBiotech Believes its Drug Candidate Natrunix Could Revolutionize Arthritis Treatment AUSTIN, Texas, May 22, 2023…
Lucy Scientific Discovery Inc.’s Functional Amanita Line Now Available for Purchase through Retail Channels
VANCOUVER, British Columbia, May 22, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. (NASDAQ: LSDI),…
Lucy Scientific Discovery Inc.’s Functional Amanita Line Now Available for Purchase through Retail Channels
VANCOUVER, British Columbia, May 22, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. (NASDAQ: LSDI),…